Listed Company

Neuren Pharmaceuticals Limited (ASX NEU)


Followers 93
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

Latest News on Neuren Pharmaceuticals Limited


Covering Neuren Pharmaceuticals Limited


Buy Hold Sell
Livewire Markets
James Gerrish
Market Matters
Ben Williamson
Fresh Equities
Carl Capolingua
Livewire Markets
Ally Selby
Livewire Markets
Hans Lee
Livewire Markets

Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is NEU. Livewire Markets has 15 experts who have published 32 articles that have featured Neuren Pharmaceuticals Limited. You can view all those wires here. The last time time NEU was featured was on the 02 May 2024 by Chris Conway in the wire “This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.”. Get the latest NEU share price and other key information like NEU Financials on Market Index.